Both in Pharmaceuticals
Revelation Biosciences vs Aptevo Therapeutics
Over the past year REVB returned −86.5% and APVO returned −95.0%; their daily moves had a correlation of 0.02.
REVB −86.5% APVO −95.0%Growth of $1, one year, split-adjusted
| Metric | REVB | APVO |
|---|---|---|
| Price | $4.54 | $1.32 |
| Market cap | $2.6M | $2.4M |
| Today | +12.04% | −2.22% |
| 1 month | −16.6% | −26.7% |
| 6 months | −39.4% | −75.3% |
| Year to date | −79.7% | −86.0% |
| 1 year | −87.0% | −95.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 552.1% | 112.5% |
| Short % of float | 0.2% | 5.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).